
|Slideshows|January 11, 2017
Interesting Neuro: Epilepsy Outcomes & Vitamin D
Author(s)Samantha J. Peterson
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.
Advertisement
We present a selection of interesting neurology articles for the month of January in the following slides. See the slide legends for links to the article summaries.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib
2
Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis
3
Rethinking Multiple Sclerosis Clinical Course Classifications in the Modern Era: Daniel Ontaneda, MD, PhD
4
Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns
5










